CHRONIC MYELOID LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for leukemia patients stuck at a treatment Dead-End
Disease control Recruiting nowThis study tests a drug called asciminib in people with a specific type of chronic myeloid leukemia (CML) that has a genetic change called T315I. This change makes the leukemia harder to treat with standard drugs. The study includes about 20 adults whose cancer did not respond to…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:10 UTC
-
Could bone marrow from deceased donors offer a new lifeline for blood cancer patients?
Disease control Recruiting nowThis early-phase study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. About 12 patients will receive either strong or milder chemotherapy before the transplant. Researchers will monit…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Leukemia care study seeks 2,000 patients to rate their own Well-Being
Knowledge-focused Recruiting nowThis study looks at how different hospital setups for chronic myeloid leukemia (CML) care impact patients' quality of life. Researchers will ask 2,000 adults with CML in Lombardy, Italy, to fill out questionnaires about their physical, emotional, and social well-being. The goal i…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Sponsor: University of Milano Bicocca • Aim: Knowledge-focused
Last updated May 26, 2026 04:20 UTC